AbbVie Inc (ABBV) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Technical Indicators
|
|
|
Bearish (2)
Neutral (7)
Bullish (18)
Performance
ABBV ROI
% from 52W High
52W Low: $138.08
28 Nov 2023
52W High: $203.87
31 Oct 2024
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
